Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface - a multicentre randomized single-masked study

Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial

(2012) Anna M. Stevens et al.   ACTA OPHTHALMOLOGICA

ComparativeIn VitroToxicology Study of Travoprost Polyquad-preserved, Travoprost BAK-preserved, and Latanoprost BAK-preserved Ophthalmic Solutions on Human Conjunctival Epithelial Cells

(2012) Françoise Brignole-Baudouin et al.   CURRENT EYE RESEARCH

Comparison of a Travoprost BAK-Free Formulation Preserved with Polyquaternium-1 with BAK-Preserved Travoprost in Ocular Hypertension or Open-Angle Glaucoma

(2011) et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Long-term Effect of BAK-free Travoprost on Ocular Surface and Intraocular Pressure in Glaucoma Patients After Transition From Latanoprost

(2011) Makoto Aihara et al.   JOURNAL OF GLAUCOMA

In Vitro Comparative Toxicology of Polyquad-Preserved and Benzalkonium Chloride-Preserved Travoprost/Timolol Fixed Combination and Latanoprost/Timolol Fixed Combination

(2011) Françoise Brignole-Baudouin et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system

(2011) Gerard Ryan et al.   BMC Ophthalmology

Effects of switching to SofZia-preserved travoprost in patients who presented with superficial punctate keratopathy while under treatment with latanoprost

(2010) Sei Yamazaki et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

In Vitro Toxicity of Topical Ocular Prostaglandin Analogs and Preservatives on Corneal Epithelial Cells

(2010) Malik Y. Kahook et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes

(2009) Maria Bafa et al.   ACTA OPHTHALMOLOGICA

Comparison of Corneal and Conjunctival Changes After Dosing of Travoprost Preserved With sofZia, Latanoprost With 0.02% Benzalkonium Chloride, and Preservative-free Artificial Tears

(2009) Malik Y Kahook et al.   CORNEA

Ocular preservatives: associated risks and newer options

(2009) Indu Pal Kaur et al.   Cutaneous and Ocular Toxicology

Prevalence of Ocular Surface Disease in Glaucoma Patients

(2009) Eamon W. Leung et al.   JOURNAL OF GLAUCOMA

Ocular Surface Tolerability of Prostaglandin Analogs in Patients with Glaucoma or Ocular Hypertension

(2009) Jess T. Whitson et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers

(2008) Hannu Uusitalo et al.   ACTA OPHTHALMOLOGICA

Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials

(2008) F Honrubia et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

In VitroEffects of Preservative-Free Tafluprost and Preserved Latanoprost, Travoprost, and Bimatoprost in a Conjunctival Epithelial Cell Line

(2008) Emmanuelle Brasnu et al.   CURRENT EYE RESEARCH

Duration of IOP Reduction With Travoprost BAK-free Solution

(2008) Ronald L. Gross et al.   JOURNAL OF GLAUCOMA

Efficacy and Tolerability of Prostaglandin Analogs

(2008) Florent Aptel et al.   JOURNAL OF GLAUCOMA